Expectations trend
FY2027 · fiscal year ending 2027-12-31 · fmp
NYSEReal EstateReit - Healthcare FacilitiesSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
Matching fiscal periods, usable estimates and at least one analyst are required.
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
The calculation requires same-period, same-provider snapshots, positive EPS, at least one analyst and a baseline within three days of the requested lookback.
The EPS and P/E reference is not available for XRN yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Complete acquisition of The Landing Alexandria for $130 million | Chiron bought a senior housing community for $130 million. | Intact | Acquisition not completed or cost deviates materially from $130 million | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-12-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is an acquisition-led real estate investment with robust earnings quality but volatile management execution. The long-term thesis is still insufficiently established, and near-term results carry meaningful uncertainty.
XRN is tagged as cheap versus peers, while the valuation model indicates a 26% premium to peers, a mixed signal that limits confidence in the comparison. The expectations gap is slightly negative, and no valuation fragility flags fired, so current pricing is classified as justified rather than unusually fragile.
Over the near term, portfolio expansion and repositioning are progressing: XRN completed acquisitions, sold seven facilities to fund reinvestment, and revenue rose modestly between the first and second quarters of 2026. The company has also issued preferred stock to support its plans, but recent quarterly misses and a high industry miss rate make the next results a key risk.
The multi-year case depends on acquisitions and capital deployment supporting durable operating performance, while the direct financial effect of governance changes remains unclear. Near term, Fed rate cuts could support real estate, but a guidance cut or weakness among sector bellwethers could weaken the setup.
For the next 1 to 3 years, XRN’s thesis has tangible expansion milestones but remains uncertain because of recent misses and volatile execution. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| The company aims for Core FFO per share near $4.38 in 2026. |
| Intact |
| Core FFO per share falls below $4.30 in 2026 |
Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Raise $100 million by issuing 1,000,000 shares of Series C Preferred Stock | It raised $100 million by selling preferred stock. | Under Pressure | Preferred stock issuance falls short of 1,000,000 shares or $100 million | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$-1.53 → $-2.01 · observed estimates
$0.16B → $0.14B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-07-24 | $-1.53 | $155,382,330 | 2 / 6 |
| 2026-07-25 | $-1.53 | $155,382,330 | 2 / 6 |
| 2026-07-26 | $-1.53 | $155,382,330 | 2 / 6 |
| 2026-07-27 | $-1.53 | $155,382,330 | 2 / 6 |
| 2026-07-28 | $-1.53 | $155,382,330 | 2 / 6 |
| 2026-07-29 | $-2.29 | $144,146,400 | 1 / 4 |
| 2026-07-30 | $-2.29 | $144,146,400 | 1 / 4 |
| 2026-07-31 | $-1.53 | $155,382,330 | 2 / 6 |
| 2026-08-01 | $-2.29 | $144,146,400 | 1 / 4 |
| 2026-08-02 | $-2.29 | $144,146,400 | 1 / 4 |
| 2026-08-03 | $-1.53 | $155,382,330 | 2 / 6 |
| 2026-08-04 | $-1.53 | $155,382,330 | 2 / 6 |
| 2026-08-05 | $-1.53 | $155,382,330 | 2 / 6 |
| 2026-08-06 | $-2.29 | $144,146,400 | 1 / 4 |
| 2026-08-08 | $-2.29 | $153,438,000 | 1 / 4 |
| 2026-08-09 | $-2.29 | $153,438,000 | 1 / 4 |
| 2026-08-10 | $-2.29 | $153,438,000 | 1 / 4 |
| 2026-08-12 | $-2.44 | $155,729,600 | 2 / 5 |
| 2026-08-13 | $-2.44 | $155,729,600 | 2 / 5 |
| 2026-08-14 | $-2.29 | $153,438,000 | 1 / 4 |
| 2026-08-15 | $-2.29 | $153,438,000 | 1 / 4 |
| 2026-08-16 | $-2.29 | $153,438,000 | 1 / 4 |
| 2026-08-17 | $-2.29 | $153,438,000 | 1 / 4 |
| 2026-08-18 | $-2.29 | $153,438,000 | 1 / 4 |
| 2026-08-19 | $-2.29 | $153,438,000 | 1 / 4 |
| 2026-08-20 | $-2.02 | $141,165,333 | 1 / 4 |
| 2026-08-21 | $-2.02 | $141,165,333 | 1 / 4 |
| 2026-08-22 | $-2.02 | $141,165,333 | 1 / 4 |
| 2026-08-23 | $-2.02 | $141,165,333 | 1 / 4 |
| 2026-08-24 | $-2.02 | $141,165,333 | 1 / 4 |
| 2026-08-25 | $-2.02 | $141,165,333 | 1 / 4 |
| 2026-08-26 | $-2.02 | $141,165,333 | 1 / 4 |
| 2026-08-27 | $-2.02 | $141,165,333 | 1 / 4 |
| 2026-08-28 | $-2.02 | $141,165,333 | 1 / 4 |
| 2026-08-29 | $-2.02 | $141,165,333 | 1 / 4 |
| 2026-08-30 | $-2.02 | $141,165,333 | 1 / 4 |
| 2026-08-31 | $-2.02 | $141,165,333 | 1 / 4 |
| 2026-09-01 | $-2.02 | $141,165,333 | 1 / 4 |
| 2026-09-02 | $-2.02 | $141,165,333 | 1 / 4 |
| 2026-09-03 | $-2.02 | $141,165,333 | 1 / 4 |
| 2026-09-04 | $-2.02 | $141,165,333 | 1 / 4 |
| 2026-09-05 | $-2.02 | $141,165,333 | 1 / 4 |
| 2026-09-06 | $-2.02 | $141,165,333 | 1 / 4 |
| 2026-09-07 | $-2.02 | $141,165,333 | 1 / 4 |
| 2026-09-08 | $-2.02 | $141,165,333 | 1 / 4 |
| 2026-09-09 | $-2.02 | $141,165,333 | 1 / 4 |
| 2026-09-10 | $-2.02 | $141,165,333 | 1 / 4 |
| 2026-09-11 | $-1.53 | $141,165,333 | 1 / 4 |
| 2026-09-12 | $-1.53 | $141,165,333 | 1 / 4 |
| 2026-09-13 | $-1.53 | $141,165,333 | 1 / 4 |
| 2026-09-14 | $-1.53 | $141,165,333 | 1 / 4 |
| 2026-09-15 | $-1.53 | $140,558,333 | 1 / 4 |
| 2026-09-16 | $-1.53 | $140,558,333 | 1 / 4 |
| 2026-09-17 | $-1.53 | $140,558,333 | 1 / 4 |
| 2026-09-18 | $-1.53 | $140,558,333 | 1 / 4 |
| 2026-09-19 | $-1.53 | $140,558,333 | 1 / 4 |
| 2026-09-20 | $-1.53 | $140,558,333 | 1 / 4 |
| 2026-09-21 | $-1.53 | $140,558,333 | 1 / 4 |
| 2026-09-22 | $-1.62 | $142,020,000 | 1 / 4 |
| 2026-09-23 | $-1.62 | $142,020,000 | 1 / 4 |
| 2026-09-24 | $-1.62 | $142,020,000 | 1 / 5 |
| 2026-09-25 | $-1.62 | $142,020,000 | 1 / 5 |
| 2026-09-26 | $-1.62 | $142,020,000 | 1 / 5 |
| 2026-09-27 | $-1.62 | $142,020,000 | 1 / 5 |
| 2026-09-28 | $-1.62 | $142,020,000 | 1 / 5 |
| 2026-09-29 | $-1.62 | $142,020,000 | 1 / 5 |
| 2026-09-30 | $-1.62 | $142,020,000 | 1 / 5 |
| 2026-10-01 | $-1.62 | $142,020,000 | 1 / 5 |
| 2026-10-02 | $-1.62 | $142,020,000 | 1 / 5 |
| 2026-10-03 | $-1.62 | $142,020,000 | 1 / 5 |
| 2026-10-04 | $-1.62 | $142,020,000 | 1 / 5 |
| 2026-10-05 | $-1.62 | $142,020,000 | 1 / 5 |
| 2026-10-06 | $-1.62 | $142,020,000 | 1 / 5 |
| 2026-10-07 | $-1.62 | $142,020,000 | 1 / 5 |
| 2026-10-08 | $-1.62 | $142,020,000 | 1 / 5 |
| 2026-10-09 | $-1.62 | $142,020,000 | 1 / 5 |
| 2026-10-10 | $-1.62 | $142,020,000 | 1 / 5 |
| 2026-10-11 | $-2.01 | $143,145,375 | 2 / 5 |
| 2026-10-12 | $-2.01 | $143,145,375 | 2 / 5 |
| 2026-10-13 | $-2.01 | $143,145,375 | 2 / 5 |
| 2026-10-14 | $-2.01 | $143,145,375 | 2 / 5 |
| 2026-10-15 | $-2.01 | $143,145,375 | 2 / 5 |
| 2026-10-16 | $-2.01 | $143,145,375 | 2 / 5 |
| 2026-10-17 | $-2.01 | $143,145,375 | 2 / 5 |
| 2026-10-18 | $-2.01 | $143,145,375 | 2 / 5 |
| 2026-10-19 | $-2.01 | $143,145,375 | 2 / 5 |
| 2026-10-20 | $-2.01 | $143,149,625 | 2 / 4 |
| 2026-10-21 | $-2.01 | $143,149,625 | 2 / 4 |
| 2026-10-22 | $-2.01 | $143,149,625 | 2 / 4 |
| 2026-10-23 | $-2.01 | $143,149,625 | 2 / 4 |
| 2026-10-24 | $-2.01 | $143,149,625 | 2 / 4 |
| 2026-10-25 | $-2.01 | $143,149,625 | 2 / 4 |
| 2026-10-26 | $-2.01 | $143,149,625 | 2 / 4 |
| 2026-10-27 | $-2.01 | $143,149,625 | 2 / 4 |
| 2026-10-28 | $-2.01 | $143,149,625 | 2 / 4 |
| 2026-10-29 | $-2.01 | $143,149,625 | 2 / 4 |
| 2026-10-30 | $-2.01 | $143,149,625 | 2 / 4 |
| 2026-10-31 | $-2.01 | $143,149,625 | 2 / 4 |
| 2026-11-01 | $-2.01 | $143,149,625 | 2 / 4 |
| 2026-11-02 | $-2.01 | $143,149,625 | 2 / 4 |
| 2026-11-03 | $-2.01 | $143,149,625 | 2 / 4 |
| 2026-11-04 | $-2.01 | $143,149,625 | 2 / 4 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 6 Buy / Strong Buy · 4 Hold · 0 Sell / Strong Sell
Recent actions · Oct 6–Nov 4 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
Next earnings date unavailable
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.